1-3 of 3
Rahul Seth
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world outcomes with teclistamab in relapsed/refractory multiple myeloma and severe renal failure: A propensity matched multi-center retrospective study using trinetx database

Free
Deevyashali Parekh, Beth Faiman, Sandra Mazzoni, Louis Williams, Jack Khouri, Hossam M. Ali, Utkarsh Goel, Jason Valent, Diana Basali, Christy Samaras, Tara Roy, Alexandra McDonald, Faiz Anwer, Majid Jaberi, Kirti Arora, Haleema Sadia Adil, Julie Bevacqua, Rahul Seth, Shahzad Raza
Journal: Blood
Blood (2025) 146 (Supplement 1): 6372.
https://doi.org/10.1182/blood-2025-6372
Published: 2025
Journal Articles

Real-world outcomes with CAR-T therapy in relapsed/refractory multiple myeloma and severe renal failure: A propensity matched multi-center retrospective Study using trinetx database

Free
Deevyashali Parekh, Sandra Mazzoni, Jason Valent, Louis Williams, Jack Khouri, Diana Basali, Kirti Arora, Saveta Mathur, Haleema Sadia Adil, Anousheh Paracha, Majid Jaberi, Faiz Anwer, Rahul Seth, Shahzad Raza
Journal: Blood
Blood (2025) 146 (Supplement 1): 4593.
https://doi.org/10.1182/blood-2025-4593
Published: 2025
Journal Articles

Preliminary Toxicity Profile of High-Dose Cyclophosphamide for Severe, Refractory Multiple Sclerosis. IND: 65863.

Free
Rahul Seth, DO, Sumeet Chandra, MD, Stevens Michelle, RN, Locher Emily, RN, Zamkoff Kenneth, MD, Gladstone E. Gladstone, MD
Journal: Blood
Blood (2004) 104 (11): 5050.
https://doi.org/10.1182/blood.V104.11.5050.5050
Published: 2004